and 3H-L-364,71 6 [ 1 -methyl-3-(2-indoloyl)amino-5-phenyl-3H-1,4 benzodiazepin-2-one] were used to localize "peripheral" CCK receptors in rat brain. In autoradiographic experiments, L-365,031 displaced i251-Bolton Hunter CCK-6 binding from the interpeduncular nucleus (IPN) (IC,, = 7 x 1Om8 M), the area postrema (AP), and the nucleus tractus solitarius (NTS) without influencing specific binding to other areas, such as the cerebral cortex or the spinal tract of the trigeminal nerve. Desulfated CCK preferentially inhibited Y-CCK binding to cerebral cortex (I&,, = 7 x lo-* M) rather than IPN (IC, > 1 x 1O-e M) or AP-NTS. In the medulla the localization of 3H-L-364,716 binding was similar to L-365,031 -sensitive Y-CCK-6 binding and was found in the AP and medial, but not lateral, aspects of the NTS. In membranes prepared from IPN, NTS, and AP, 3H-364,716 binding was of high affinity (Kd = 0.14 nM), saturable b%,X = 20 fmol/mg protein), and inhibited by compounds previously shown to act at pancreatic CCK receptors. The receptors labeled by 3H-364,7 16 were modulated by guanyl nucleotide, which reduced agonist affinity lo-fold without affecting antagonist binding. The localization and high density of CCK receptors in AP and NTS suggest that these receptors may play an important role in processing sensory afferent information.
Cholecystokinin (CCK) is present in high concentrations in the mammalian CNS (Vanderhaeghen et al., 1975 (Vanderhaeghen et al., , 1980 Dockray, 1976; Innis et al., 1979) . Indeed, as the sulfated octapeptide (sCCK-8), it is found in certain brain regions in higher concentrations than any other neuropeptide (see Crawley, 1985, for review) . The distribution of sCCK-8 throughout the CNS, its localization in neuronal perikarya and nerve fibers, and its coexistence with other putative neurotransmitters (HBkfelt et al., 1980; Greenwood et al., 198 1; Vanderhaeghan et al., 198 1; Kubota et al., 1983; Hamill et al., 1984) suggest that this peptide may act as either a neurotransmitter or a neuromodulator. Additionally, the demonstration of binding sites with high affinity for sCCK-8 and related peptide fragments throughout the brain further supports the notion that sCCK-8 might be considered as an important mediator of information transfer between neurons.
Biochemical measurements of the affinity of CCK fragments at brain CCK receptors have shown that these differ in their pharmacological specificity when compared with CCK receptors in peripheral organs such as the pancreas or gallbladder (Innis and Snyder, 1980; Saito et al., 1980) . For example, "peripheral" CCK receptors display lower affinity for desulfated CCK-8 and gastrin than do "central" CCK receptors found in the brain. Despite such differences between receptors in anatomically separate tissues, those within the CNS have generally been considered as being homogeneous, with no evidence of subtypes in different brain regions. Recently, however, Moran and colleagues (1986) reported that CCK receptors in the area postrema (AP), the nucleus tractus solitarius (NTS), and the interpeduncular nucleus (IPN) display relatively low affinity for desulfated CCK and may therefore represent "peripheral" type CCK receptors despite their location in central nervous tissue.
Recent developments in our laboratories have yielded a number of highly potent nonpeptide CCK-receptor antagonists that are selective for peripheral CCK receptors (Chang and Lotti, 1986; Evans et al., 1986) . As such, these compounds provide very specific probes for determining whether peripheral type CCK receptors do exist in areas of mammalian brain. The present report describes the use of 2 such selective CCK antagonists in demonstrating the existence of CCK receptors in rat brain which resemble those in the periphery. In the first part of the study, autoradiography was employed to visually demonstrate these sites, with 2 different approaches to detection: first, indirectly, by labeling receptors using 'Y-Bolton Hunter CCK-8 (LZSI-BH-CCK) and displacing with an unlabeled antagonist L-365,03 1 [ l-methyl-3-(4-bromobenzoyl)amino-5-phenyl-3H-1,4-benzodiazepin-2-one], which shows high selectivity for peripheral CCK receptors (Chang and Lotti, personal communication) ; second, by direct visualization using a tritium-labeled antagonist of even greater selectivity L-364,7 18 [ 1 -methyl-3-(2-indoloyl) amino-5-phenyl-3H-1,4-benzodiazepin-2-one] (Chang and Lotti, 1986; Chang et al., 1986a) . Furthermore, the high affinity and selectivity of 3H-L-364,718 has permitted us to characterize these receptors using membrane preparations. Our results suggest that the CCK receptors localized in the AP, NTS, and IPN of rat brain are of the peripheral type, termed CCK-A receptors by Moran et al. (1986) .
Materials and Methods Autoradiography
Brains were removed from male Sprague-Dawley rats (200-250 gm) and rapidly frozen. Sections 10 pm thick were cut on a cryostat and then mounted onto glass slides. The sections were allowed to dry and were stored at -20°C until required. On the day of use, sections were i n Rat CNS , and L-365031. Membrane homogenateswere incubated with 0.1 nM 1251-BHCCK-8 for 120 min at room temperature alone or with increasing concentrations of test compound. Nonspecific binding was determined bv 1 WM sCCK-8, which was subtracted from total to give the specific portion of binding. Data are mean values from 2 experiments. L-365.031 disnlaved lOOO-fold hiaher affinitv for CCK receptors in the pancreas than in the brain. In contr&, desulfated CCK-8 showed a lower degree of selectivity for central receptors relative to sCCK, on the order of 2-to lo-fold. thawed and then incubated in an assay buffer containing either lz51-CCK-8 labeled with Bolton and Hunter reagent (0.6 nM; Amersham International) or 'H-L-364,7 18 (5 nM; prepared by Dr. Avery Rosegay of MSD Laboratories, Rahway, NJ). Sections were incubated either in the presence of ligand alone or with varying amounts of unlabeled compound. The composition of the assay buffer for all incubations was 20 mM HEPES (pH 6.5), 5 mM MgCl,, 150 mM NaCl, 1 mM EGTA, and 0.025% bacitracin. The incubation was allowed to proceed for 60 min at room temperature, after which the sections were washed 4 times for 2 min in fresh buffer and then dried in a stream of air. Autoradiographs were generated by apposing sections to LKB-Ultrofilm for 7 d (for Y-CCK-8) or 8 weeks (for 3H-L-364,7 18). The resulting negatives were analyzed using a Quantimet 920 image analyzer (Cambridge Instruments), and calibration was by means of brain paste standards prepared according to Clark and Hall ( 1986) .
In order to verify the localization of binding in sections of medulla, sections labeled with Y-CCK were apposed for 7 d to coverslips that had been dipped in Ilford K5 emulsion. These were then developed, fixed, and washed several times before allowing them to dry. The tissue sections were stained using cresyl fast violet and the coverslips fixed in position with DPX mounting medium. The slides were viewed under normal illumination for histological examination and under dark-field illumination for visualization of silver grains.
Tissue preparations
Guinea pig cortex. The brains were removed from adult guinea pigs (300-400 gm) and the cortex dissected free of other tissue. This was then homogenized in 20 vol of ice-cold 0.32 M sucrose using a glass homogenizer and Teflon pestle. The homogenate was centrifuged at 1000 x ,a for 10 min, after which the superantant was recentrifuged at 48,000 x gfor 20 min. The resulting pellet was resuspended in standard assav buffer (SAB) (20 mM HEPES. DH 6.5.5 mM M&l,. 150 mM NaCl. 1 rnh EGTA, and i).O25% bacitrach) at a'tissue concentration of 1 gm original wet weight to 40 ml assay buffer.
Rut pancreas. The pancreas was removed from male Sprague-Dawley rats and homogenized for 15 set in 20 vol of ice-cold buffer comprising 10 mM HEPES, pH 7.4, plus 0.01% soybean trypsin inhibitor (SBTI) using a Polytron homogenizer. The tissue was centrifuged for 15 min at 48,000 x g and the pellet resuspended in SAB supplemented with 0.01% SBTI and 0.2% BSA. The final tissue concentration in the assay was 1 gm original wet weight of tissue to 4000 ml of assay buffer.
Rat, AP, NTS, and IPN. After removal of the brains from SpragueDawley rats, a 2 mm slice of tissue containing the IPN was cut just caudal to the hypothalamus using a pair of parallel-mounted razorblades. Similarly, a slab of tissue was cut from the medulla, 2 mm rostra1 to the beginning of the obex. From each of these slices, the appropriate area was dissected away from surrounding tissue, and for each assay the combined tissue from 13 rats was used. After dissection, the tissue was transferred immediately and maintained in ice-cold Krebs-Henseleit prior to homogenization in 10 mM HEPES, pH 7.4, with a glass homogenizer fitted with a Teflon pestle. The tissue homogenate was then centrifuged for 15 min at 48,000 x g, and the pellet was finally resuspended in SAB at a tissue concentration of approximately 10 mg original wet weight/ml buffer.
Binding assays
The protocol for each binding assay was essentially the same, with only details differing. Aliquots of tissue were incubated at 20°C for either 60 min with 'H-L-364.718 (0.2-0.3 nM with AP. NTS. and IPN) or 120 min with IZ51-BH-CCK (6.1 nM with guinea pig brain or rat pancreas). Test compounds were included over a range of concentrations, and nonspecific binding was determined using either 1 PM sCCK-8 for "central" type receptors or 1 PM L-365,031 for "peripheral" type receptors. Saturation analysis was performed in a similar way, with the concentration of ligand being increased from 0.02 nM upwards. After each incubation, assays were terminated by filtration onto Whatman GF/C filters using a B&de1 cell harvester, and the filters were washed a further 4 times with 3 ml of 20 mM HEPES. DH 6.5. The radioactivitv associated with the filters was then counted using either a gamma-counier or liquid scintillation counter. to displace lZSI-CCK binding from CCK receptors in cortex and IPN. Figure 2 shows an example of inhibition of **SI-CCK binding to coronal sections of rat brain by dCCK ( 1O-6 M) and L-365,03 1 ( 1O-6 M). In addition, Figure 3 presents a quantitative estimate of the degree of inhibition produced by each compound in the IPN and cortex. L-365,031 failed to inhibit binding by more than 10% in the cerebral cortex at concentrations that were found to be maximally effective in pancreas binding assays (compare Figs. 3 and lE?>. In the IPN, however, L-365,031 produced a dose-dependent reduction in specific 1251-CCK binding (Fig. 3B) . The data shown in this figure were fitted by a single hyperbolic function, which yielded an IC,, value of 6.6 x 1O-8 M for L-365,03 1, together with a Hill coefficient of 1.00. By contrast, dCCK displayed greater affinity for receptors in the cortex than in the IPN (Fig. 3) , thus agreeing with the observations of Moran et al. (1986) . An IC,, value of 7 x lo-* M (Hill slope, 0.74) was obtained for the data shown, which is close to that found in guinea pig cortex (see above) and that determined autoradiographically (2 x 1O-8 M) for dCCK by Moran and colleagues (1986) .
Another series of experiments was performed to determine the localization of 1*51-CCK binding sites in hindbrain, and the sensitivity of these sites to L-365,031. Figures 4 and 5 show autoradiographs of rat medulla made using emulsion-coated coverslips or LKB-Ultrofilm, respectively. These sections were taken at approximately bregma -14 mm according to the atlas of Paxinos and Watson (1982) . Specific lZ51-CCK binding was localized principally to the regions of the area postrema, the nucleus tractus solitarius and also to the spinal tract of the trigeminal nerve (Sp5). The presence of L-365,031 inhibited binding in the AP but failed to modify binding to the trigeminal nerve tract (Fig. 5A) . Sulfated CCK-8 itself displaced binding to AP, NTS, and Sp5 (data not shown).
The density of binding in the area postrema and medial NTS increased progressively in a rostra1 direction but remained sensitive to inhibition by L-365,031 (Figs. 4, B, C, 5, B, C) . However, binding in the lateral aspects of the NTS was refractory to the antagonist (Figs. 4, E, F; 5D ), suggesting that these sites are of the classical brain type.
L-364,7 18 displays even greater affinity and selectivity for peripheral CCK receptors than does L-365,03 1 (Chang and Lotti, 1986 ) and it has been used in tritiated form to label pancreatic CCK receptors directly (Chang et al., 1986a) . We have therefore used this compound in autoradiographic experiments to directly label peripheral CCK receptors present in caudal regions of rat brain.
Specific binding of 3H-L-364,718 in the rat medulla was localized exclusively to regions of the AP and medial aspects of the NTS (Fig. 6) . Neither the spinal tract of the trigeminal nerve nor lateral aspects of the NTS were labeled by the radioligand, agreeing with the pattern of displacement seen with lZ51-CCK and L-365,03 1 (compare Figs. 5 and 6). In more rostra1 sections of medulla, bilateral areas of relatively heavy labeling could be detected, which represented binding in the medial nucleus of the NTS (Fig. 6, C, D) , but lateral aspects of the NTS were not labeled by 3H-L-364,7 18 (compare Figs. 5D and 60 ).
3H-L-364,718 binding to AP, NTS, and IPN membranes
The extremely high affinity and selectivity of 3H-L-364,7 18 for peripheral type CCK receptors also allowed this compound to be used as a radioligand to characterize "peripheral" sites present in brain using a more convenient membrane binding assay. For this purpose, the AP, NTS, and IPN were dissected and used to prepare a crude membrane preparation.
Binding of 3H-L-364,7 18 to membrane fragments prepared from AP, NTS, and IPN was both saturable and of very high affinity, with maximum binding capacity (B,,,) of 20.3 f 3.9 fmol/mg protein (n = 3) and dissociation constant (&) of 0.14 nM (pK, = 9.58 + 0.22, n = 4). At concentrations used for displacement studies (0.2-0.3 nM), the specific portion of binding represented between 50-60% of total binding and was highly reproducible between assays. Binding was displaced by a variety of CCK-related peptide fragments and Table 1 shows mean pIC,, values for these. Sulfated CCK-8 was the most potent peptide tested (pIC,, = 7.8 f 0.08) being equipotent with the nonpeptide antagonist L-365,031 (pIC,, = 7.9 + 0.3). Desulfated CCK was about 100 times less potent than the sulfated octapeptide. Gas&in, CCK-4, and CCK-6 were essentially inactive as inhibitors of binding (pIC,, < 4.0). The opiate agonist tifluadom, which possesses a benzodiazepine structure and has been shown to have antagonist activity at peripheral CCK receptors in pancreas and gallbladder (Chang et al., 1986b) , was also active at central CCK receptors labeled by 3H-L-364,7 18.
CCK receptors in pancreatic membranes have been shown to be sensitive to modulation by guanyl nucleotides such as GTP and its more stable analogs (Innis and Snyder, 1980) . To deThe inclusion of GppNHp in the assay medium had no effect termine whether the binding sites present in the AP and IPN on the binding of the antagonist itself However, the affinity of also shared this property, the effects of 100 PM GppNHp on 3H-sCCK-8 for the binding sites was reduced by approximately an 364,718 binding and on the affinity of CCK as an inhibitor of order of magnitude from pIC,, = 7.7 + 0.03 under control binding were determined.
conditions to pIC,, = 6.5 + 0.12 in the presence of GppNHp +L-365,031 Total Binding TS Figure 6 . Localization of 3H-L-364,718 binding to sections of rat medulla. Sections (10 pm) of rat medulla were incubated either with 5 IUI 3H-G364,7 18 alone or in the presence of lo-' M L-365,03 1. After washing and drying, the sections were apposed to LKB Ultrofilm for generation of autoradiographs. 3H-G364,7 18 binding is shown by white grams. Binding of -'H-L-364,7 18 that was displaceable by L-365,03 1 or CCK ( 1O-6 M) was localized to the area Ap and medial portions of the NTS (A and B) . Bilateral areas of relatively heavy labeling were localized to the medial LTS (mNTS), but no displaceable binding could be detected in the spinal tract of the trigeminal nerve or lateral aspects of the NTS. Compare with Figures 4D-F and 5D , for instance. The inclusion of the guanyl nucleotide in the incubation medium had no effect on the binding of )H-364,7 18 itself but reduced the affinity of sCCK-8 for the receptor sites approximately lofold. Additionally, the Hill slope was raised to near unity. Data are the mean values from 3 separate experiments.
( Fig. 7) . Furthermore, the Hill slope increased from 0.5 f 0.06 to 0.9 2 0.17 in the presence of the nucleotide.
Discussion
We have shown that, in discrete areas of rat brain, there exist CCK receptors that are sensitive to compounds having high affinity and selectivity for peripheral CCK receptors. A clear distinction between receptors for CCK present in the IPN and also the AP-NTS complex and those located in most other areas of the brain is the high affinity shown by AP, IPN, and NTS sites for the nonpeptide antagonists L-365,031 and L-364,718. The present work therefore confirms and enlarges upon the original observations of Moran et al. (1986) . These authors reported that binding of lZ51-CCK-33 in the AP-NTS, IPN, and also posterior hypothalamic nuclei was less sensitive to inhibition by desulfated CCK than binding in the cerebral cortex, a pattern similar to that seen with lZ51-CCK-binding to pancreatic membranes (Innis and Snyder, 1980) . However, subclassification of peptide hormone receptors according to differences in the affinity of peptides with fairly limited degrees of selectivity is problematic, especially in view of the susceptibility of peptides to endogenous metabolic enzymes. The use of nonpeptide antagonists having high degrees of selectivity provides a much better basis upon which to classify receptor subtypes, both within and without the CNS. The close agreement between the affinity of L-365,031 for CCK receptors in the pancreas and those in the AP-NTS complex, together with the direct labeling of the brain receptors with 3H-L-364,7 18, is reconcilable only with the fact that the receptors in these areas are truly of the peripheral type, termed CCK-A or alimentary receptors by Moran and colleagues. In fact, the pharmacological profile of compounds inhibiting 3H-L-364,7 18 binding to membranes prepared from the discrete brain areas is very similar to that reported using pancreatic membranes and LZ51-CCK (Sankaran et al., 1979; Innis and Snyder, 1980; Steigerwalt and Williams, 198 1; Williams et al., 1986) or 3H-L-364,718 (Chang et al., 1986a) . The localization of L-365,03 1 -sensitive lZ51-CCK binding and of 3H-L-364,7 18 itself were identical in the areas examined. 3H- 18 either alone or in the presence of a range of test compound. Nonspecific binding was measured using 1 MM L-365,031 and was subtracted from total binding to give the specific portion. Values are geometric means f SEM of the negative logarithm of the molar concentration producing 50% inhibition of specific binding from between 3 and 6 separate experiments.
L-364,7 18 may therefore be considered the ligand of choice for imaging these receptor sites, especially in view of the good definition given by tritium in autoradiographic experiments. However, by using both 1251-CCK and displacing with "cold" antagonist, as well as labeling directly with 3H-L-364,718, complementary information concerning the relative distribution of "central" and "peripheral" sites was obtained, even within a narrowly defined anatomical region such as the AP-NTS complex. Thus, the occlusion of "A" sites in certain parts of the NTS allowed detection of a binding that was of the type usually found within the CNS-high affinity for dCCK and low affinity for L-364,718 or L-365,031 (CCK-B receptor). Conversely, direct labeling with 3H-L-364,7 18 allowed the localization of "A" sites to be made in an uncompromised fashion, and the results strongly suggest that regional densities of binding within the NTS vary from the medial to lateral portions of the nucleus. Such variations in binding density within the nucleus may be associated with afferent input via the vagus from a particular anatomical region (Berger, 1979; Kalia and Mesulam, 1980; Higgins and Schwaber, 198 1; Leslie et al., 1982) . Nonetheless, the highest density of CCK-A sites was found in regions of the area postrema. Perhaps this is not totally surprising in view of the afferent vagal input to the area from peripheral organs such as the stomach (Leslie et al., 1982) and the high CCK content of the vagus itself (Dockray et al., 1980; Palkovitz et al., 1982) . Visualization of the projections of the vagus into the AP and NTS using HRP (Kalia and Sullivan, 1982) parallels the distribution of 3H-L-364,7 18 binding in this area, suggesting the involvement of CCK-A receptors in the processing of afferent information within this nucleus. Indeed, sulfated CCK-8 administered peripherally or directly to the NTS has been shown to have profound effects on both cardiovascular and respiratory function in the cat, effects not mimicked by compounds with low affinity for the CCK-A sites, for example, CCK-4 and desulfated CCK @enavit- Saubie et al., 1985) . Furthermore, sCCK-8 (but not dCCK) has been shown to inhibit respiratory neurons in the NTS (Morin et al., 1983) which again suggests the involvement of CCK-A receptors. Why peripheral type receptors should be present in other areas such as the IPN is unclear, as, in contrast to the AP, the IPN is located well within the blood-brain barrier. CCK-like im-munoreactivity is present in cell bodies located on the rostra1 margins of the nucleus, and dense networks of fiber plexi, which also show CCK-like immunoreactivity, can be detected surrounding the IPN (Kubota et al., 1983; Hamill et al., 1984) . However, the density of these is much less within the nucleus itself. Despite that the exact function of the IPN remains unclear, it is probable that if released from fibers around the IPN, CCK would act at A-type CCK receptors.
Finally, the sensitivity to guanyl nucleotide shown by CCK-A receptors in AP, NTS, and IPN is another feature shared with their peripheral counterparts (Innis and Snyder, 1980) . This modulation of agonist, but not of antagonist, binding by GppNHp reflects the linkage of the receptor to one of a series of GTPbinding proteins (see Rodbell, 1980) and the ability to form a ternary complex when activated. Pancreatic receptors stimulate phosphoinositol (PI) turnover (Hokin-Neaverson and Sadeghian, 1984; Lin et al., 1986) and have also been shown to stimulate adenylate cyclase (Svoboda et al., 1976) , although PI metabolism is more likely to be linked to enzyme secretion. CCK-B receptors may also be linked to a GTP-binding protein in a similar way (Innis and Snyder, 1980 ; but see Van Dijk et al., 1984 ), yet they do not appear to be linked to a second messenger, as neither PI turnover nor adenylate cyclase is stimulated. Clearly, one intriguing question for the future is whether brain CCK-A receptors are linked to PI turnover or cyclase or whether, like their more ubiquitous CNS counterparts, they are linked to a G-protein other than Gs, Gi, or Gp. In conclusion, the present work demonstrates the existence of subtypes of CCK receptors within the rat CNS that are sensitive to nonpeptide compounds previously shown to have high affinity and selectivity for pancreatic CCK receptors. These receptors have been further characterized by binding studies using membranes prepared from the AP-NTS complex and IPN using 3H-L-364,7 18; the pharmacological specificity of brain sites labeled with this radioligand is similar to that seen in the pancreas. The determination of the function of such receptors within the brain awaits further study, but this should be facilitated by the use of nonpeptide antagonists that are selective for CCK-A receptors present in periphery and CNS.
